Alprostadil (Prostavasin®) | UCB
UCB's Global Corporate Website

Alprostadil (Prostavasin®)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Intermittent Claudication Prostaglandin E1 in Outpatients With Intermittent Claudication Phase 3 SP0580
Completed
NCT01263925 LINK
Schellong SM, et al. Vasa;2017,46(5):403-405
Peripheral Arterial Occlusive Disease Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (ESPECIAL) Phase 4 SP0777
Completed
NCT00596752
2005-001970-29
LINK
LINK
Lawall, H. et al. Eur J Vasc Endovasc Surg;2017, 53(4):559-566
Macular Degeneration Alprostadil in Maculopathy Study (AIMS) Phase 3 SP0878
Terminated
NCT00619229
2005-005686-11
LINK
LINK
"Augustin et al. Expert Opin Investig Drugs;2013;22;7;803-812. "